Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Contact






Share this:

  • Facebook
  • Twitter
  • Google
  • Pinterest
  • LinkedIn
  • Tumblr
  • Reddit
  • Pocket
  • Print
  • Email

Like this:

Like Loading...
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

Twitter Updates

My Tweets

RSS Google Ovarian Cancer News

  • This RSS feed URL is deprecated October 22, 2018
  • Report: Women Everywhere Don't Know Enough About Ovarian Cancer - NPR October 21, 2018
  • Practice-Changing PARP Inhibitor Study in Ovarian Cancer - MedPage Today October 21, 2018
  • Experimental regimen prolongs PFS in recurrent ovarian cancer - Healio October 21, 2018
  • Can Low-Dose Aspirin Lower Ovarian Cancer Risk? - Cancer Network October 19, 2018
  • Niraparib Effective in Later Lines of Therapy for Relapsed Ovarian Cancer - OncLive October 20, 2018
  • Psychosocial therapy reduces fear of disease progression among women with ovarian cancer - Healio October 20, 2018
  • ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress - News-Medical.net October 22, 2018
  • Diagnosis of ovarian cancer delayed by woeful lack of awareness - EurekAlert (press release) October 18, 2018
  • Why ovarian cancer is hard to detect - KXLY Spokane October 17, 2018
  • Six early signs of ovarian cancer to watch out for - The Standard October 22, 2018

Top Posts

  • Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
    Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
  • About
    About
  • 2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
    2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
  • "Adoptive T-Cell" Immunotherapy Shows Activity Against Advanced Ovarian Cancer in Phase I Study
    "Adoptive T-Cell" Immunotherapy Shows Activity Against Advanced Ovarian Cancer in Phase I Study
  • Alternative & Complementary Therapy
    Alternative & Complementary Therapy
  • Cancer Survivors With Low Volume Metastases May Benefit From Radiotherapy
    Cancer Survivors With Low Volume Metastases May Benefit From Radiotherapy
  • Æterna Zentaris' LHRH-Receptor Targeted Therapy AEZS-108 Produces Positive Preliminary Results in Advanced Stage Ovarian Cancer
    Æterna Zentaris' LHRH-Receptor Targeted Therapy AEZS-108 Produces Positive Preliminary Results in Advanced Stage Ovarian Cancer
  • Making A Difference: L'Oréal Paris Honors Women of Worth at Special Ceremony in New York City
    Making A Difference: L'Oréal Paris Honors Women of Worth at Special Ceremony in New York City
  • Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients
    Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients
  • FDA Awards $1.6M Orphan Drug Grant for Clinical Phase II Development of EGEN-001 for Treatment of Ovarian Cancer
    FDA Awards $1.6M Orphan Drug Grant for Clinical Phase II Development of EGEN-001 for Treatment of Ovarian Cancer

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 483,168 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 2,115 other followers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer October 17, 2018
  • Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient October 15, 2018
  • Study of Avelumab + M6620 + Carboplatin in Poly (Adenosine Diphosphate Ribose [ADP]-Ribose) Polymerase Inhibitor (PARPi)-Resistant Recurrent Ovarian Cancer October 12, 2018
  • An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) October 8, 2018

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • SHR-1701 in Metastatic or Locally Advanced Solid Tumors October 18, 2018
  • Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer October 18, 2018
  • Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma October 16, 2018
  • Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors October 17, 2018
  • PET Study With [89Zr]-Df-CriPec® Docetaxel October 19, 2018
  • A Dose Escalation and Expansion Study of RO7121661, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors October 17, 2018
  • PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors October 15, 2018
  • Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors October 12, 2018
  • Intratumoral Injection of Autologous CD1c (BDCA-1)+ myDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab October 16, 2018
  • A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-931 in Participants With Advanced Solid Tumors October 17, 2018

RSS Medical Studies

  • Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells.
  • Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors.
  • Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.
  • IRE1α-XBP1 Suppresses the Antitumor Activity of T Cells.
  • Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.

Recent Comments

Paul Cacciatore on About
Building a Team for… on About
Kathleen on About
Paul Cacciatore on About
Liz on About
Paul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini on Dana Farber Webchat: The Lates…
painspeaks on SU2C Announces the Formation o…
marcy westerling on SU2C Announces the Formation o…
anne on Dana-Farber Oncologists Differ…
Personalized Medicin… on 2011 ASCO: Matching Targeted T…
YoTrip Presents: Sep… on U.S. President Barack Obama Pr…
Paul Cacciatore on U.S. President Barack Obama Pr…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: